Early in the COVID epidemic, it became clear that the virus often causes a cytokine storm, leading to immunopathological organ damage.   The first major study to suggest benefit from steroid in COVID was a retrospective study by Wang et al. released in early March, which found reduced mortality among COVID patients with ARDS who were … Continue reading PulmCrit – Dexamethasone & COVID – a study in immunopathology, evidence-based medicine, and ourselves